---
figid: PMC7322178__gr5
figlink: pmc/articles/PMC7322178/figure/fig5/
number: F5
caption: Metabolic impact of tyrosine kinase inhibitor (TKI) administration. The inhibition
  of different receptor tyrosine kinase (RTK) alters all cancer hallmarks. Dovitinib,
  Imatinib, Gefitinib, Erlotinib and Capmatinib reduce glycolytic pathway, while Sorafenib
  promoted mitochondrial dysfunction. Lipid synthesis and protein synthesis were profoundly
  altered by TKIs. ETC; Electron transport chain.
pmcid: PMC7322178
papertitle: Integrated molecular signaling involving mitochondrial dysfunction and
  alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer.
reftext: María A. Rodríguez-Hernández, et al. Redox Biol. 2020 Sep;36:101510.
pmc_ranked_result_index: '342'
pathway_score: 0.9021125
filename: gr5.jpg
figtitle: Metabolic impact of tyrosine kinase inhibitor (TKI) administration
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7322178__gr5.html
  '@type': Dataset
  description: Metabolic impact of tyrosine kinase inhibitor (TKI) administration.
    The inhibition of different receptor tyrosine kinase (RTK) alters all cancer hallmarks.
    Dovitinib, Imatinib, Gefitinib, Erlotinib and Capmatinib reduce glycolytic pathway,
    while Sorafenib promoted mitochondrial dysfunction. Lipid synthesis and protein
    synthesis were profoundly altered by TKIs. ETC; Electron transport chain.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - PDGFRA
  - EGFR
  - FLT1
  - FLT4
  - KDR
  - WDTC1
  - RET
  - HRAS
  - KRAS
  - NRAS
  - MTOR
  - ERBB2
  - MTTP
  - CLU
  - C2
  - Axitinib
  - Afatinib
  - Canertinib
  - Axitinib Leflunomide
  - Dasatinib Nilotinib
  - Dovitinib
  - Lenvatinib
  - Pazopanib
  - Regorafenib
  - Semaxinib
  - Sapmatinib
  - Erlotinib
  - Gefitinib
  - Dovitinib Regorafenib
  - Imatinib Sorafenib
  - Lenvatinib Sunitinib
  - Lapatinib
  - Osimertinib
  - Imatinib
  - Sorafenib
  - Sunitinib
  - Vandetanib
  - Capmatinib
  - Cabozantinib
  - Crizotinib
  - Glucose
  - ADP
  - Pentose phosphate ATP
  - Neratinib
  - Aleetinib
  - Amino acids
  - Brigatinib
  - Lactate
  - H
  - Bosutinib
  - Dasatinib
  - Acetyl
  - TCA
  - Nilotinib
  - Oxalacetate
  - Ponatinib
  - Citrate
  - ketoglutarate
genes:
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: RET/e-Met
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: RET
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Abl
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: CII
  symbol: CLI
  source: hgnc_prev_symbol
  hgnc_symbol: CLU
  entrez: '1191'
- word: CII
  symbol: C2
  source: hgnc_symbol
  hgnc_symbol: C2
  entrez: '717'
chemicals:
- word: Axitinib
  source: MESH
  identifier: C503983
- word: Afatinib
  source: MESH
  identifier: C522924
- word: Canertinib
  source: MESH
  identifier: C420268
- word: Axitinib Leflunomide
  source: MESH
  identifier: C503983
- word: Dasatinib Nilotinib
  source: MESH
  identifier: C498826
- word: Dovitinib
  source: MESH
  identifier: C500007
- word: Lenvatinib
  source: MESH
  identifier: C531958
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Regorafenib
  source: MESH
  identifier: C559147
- word: Semaxinib
  source: MESH
  identifier: C116890
- word: Sapmatinib
  source: ''
  identifier: ''
- word: Erlotinib
  source: MESH
  identifier: C400278
- word: Gefitinib
  source: MESH
  identifier: C419708
- word: Dovitinib Regorafenib
  source: MESH
  identifier: C500007
- word: Imatinib Sorafenib
  source: MESH
  identifier: C097613
- word: Lenvatinib Sunitinib
  source: MESH
  identifier: C531958
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Osimertinib
  source: ''
  identifier: ''
- word: Imatinib
  source: MESH
  identifier: C097613
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Vandetanib
  source: MESH
  identifier: C452423
- word: Capmatinib
  source: ''
  identifier: ''
- word: Cabozantinib
  source: MESH
  identifier: C558660
- word: Crizotinib
  source: MESH
  identifier: C551994
- word: Glucose
  source: MESH
  identifier: D005947
- word: ADP
  source: MESH
  identifier: D000244
- word: Pentose phosphate ATP
  source: MESH
  identifier: D000255
- word: Neratinib
  source: MESH
  identifier: C487932
- word: Aleetinib
  source: ''
  identifier: ''
- word: Amino acids
  source: MESH
  identifier: D000596
- word: Brigatinib
  source: ''
  identifier: ''
- word: Lactate
  source: MESH
  identifier: D019344
- word: H
  source: MESH
  identifier: D006859
- word: Bosutinib
  source: MESH
  identifier: C471992
- word: Dasatinib
  source: MESH
  identifier: C488369
- word: Acetyl
  source: MESH
  identifier: C011632
- word: TCA
  source: MESH
  identifier: C000589078
- word: Nilotinib
  source: MESH
  identifier: C498826
- word: Oxalacetate
  source: ''
  identifier: ''
- word: Ponatinib
  source: MESH
  identifier: C545373
- word: Citrate
  source: MESH
  identifier: C102006
- word: ketoglutarate
  source: MESH
  identifier: C029743
diseases: []
figid_alias: PMC7322178__F5
redirect_from: /figures/PMC7322178__F5
figtype: Figure
---
